Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACTNYSE:EQHNASDAQ:ERIENYSE:RYAN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$36.85+0.3%$35.73$29.99▼$37.86$5.51B0.57359,621 shs340,051 shsEQHEquitable$56.08+3.1%$52.15$36.46▼$56.79$16.53B1.152.55 million shs2.61 million shsERIEErie Indemnity$340.73-0.2%$362.12$336.15▼$547.00$15.77B0.37154,894 shs191,208 shsRYANRyan Specialty$67.30+0.3%$68.28$55.67▼$77.16$17.61B0.7970,318 shs617,722 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact+0.27%+2.73%+3.16%+7.12%+21.14%EQHEquitable+3.06%+6.07%+4.04%+8.61%+38.25%ERIEErie Indemnity-0.17%-2.25%-3.59%-17.03%-5.09%RYANRyan Specialty+0.30%+1.01%-4.07%-7.78%+16.87%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACTEnactN/AN/AN/AN/AN/AN/AN/AN/AEQHEquitable3.7541 of 5 stars2.53.02.50.02.72.52.5ERIEErie Indemnity1.546 of 5 stars0.00.04.20.02.41.71.9RYANRyan Specialty3.9803 of 5 stars3.34.00.80.01.64.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACTEnact 0.00N/AN/AN/AEQHEquitable 2.92Moderate Buy$61.679.97% UpsideERIEErie Indemnity 0.00N/AN/AN/ARYANRyan Specialty 2.58Moderate Buy$75.5812.30% UpsideCurrent Analyst Ratings BreakdownLatest EQH, RYAN, ACT, and ERIE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2025EQHEquitableUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$77.00 ➝ $75.005/19/2025EQHEquitableMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$58.00 ➝ $67.005/19/2025RYANRyan SpecialtyMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$78.00 ➝ $80.005/13/2025RYANRyan SpecialtyThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$74.00 ➝ $81.005/7/2025EQHEquitableKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$61.00 ➝ $63.005/5/2025ACTEnactUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $40.005/5/2025ACTEnactKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$39.00 ➝ $39.005/1/2025EQHEquitableWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$59.00 ➝ $61.005/1/2025EQHEquitableEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$69.00 ➝ $64.004/11/2025RYANRyan SpecialtyBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$88.00 ➝ $83.004/10/2025EQHEquitableWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$62.00 ➝ $59.00(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTEnact$1.20B4.60$4.69 per share7.86$32.53 per share1.13EQHEquitable$12.44B1.37$9.42 per share5.95$6.18 per share9.07ERIEErie Indemnity$3.80B4.15$14.35 per share23.74$43.02 per share7.92RYANRyan Specialty$2.52B7.02$2.65 per share25.40$4.19 per share16.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTEnact$688.07M$4.448.308.031.8356.93%14.44%11.01%7/30/2025 (Estimated)EQHEquitable$1.31B$3.6815.246.76N/A8.50%79.05%0.67%7/29/2025 (Estimated)ERIEErie Indemnity$600.31M$11.7529.0023.83N/A15.73%31.37%21.53%7/24/2025 (Estimated)RYANRyan Specialty$94.67M$0.34197.9524.301.796.97%47.70%5.69%7/30/2025 (Estimated)Latest EQH, RYAN, ACT, and ERIE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/24/2025Q2 2025ERIEErie Indemnity$3.55N/AN/AN/A$1.09 billionN/A5/1/2025Q1 2025RYANRyan Specialty$0.39$0.39N/A-$0.22$680.80 million$690.17 million4/30/2025Q1 2025ACTEnact$1.12$1.10-$0.02$1.08$302.28 million$306.78 million4/29/2025Q1 2025EQHEquitable$1.49$1.35-$0.14$0.16$4.05 billion$4.58 billion4/24/2025Q1 2025ERIEErie Indemnity$3.19$2.65-$0.54$2.65$766.98 million$989.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTEnact$0.842.28%N/A18.92%3 YearsEQHEquitable$1.081.93%N/A29.35%2 YearsERIEErie Indemnity$5.461.60%N/A46.47%36 YearsRYANRyan Specialty$0.480.71%N/A141.18%1 YearsLatest EQH, RYAN, ACT, and ERIE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/22/2025ERIEErie Indemnityquarterly$1.36501.6%7/8/20257/8/20257/22/20255/19/2025ACTEnactquarterly$0.212.35%5/19/20255/19/20256/11/20255/21/2025EQHEquitablequarterly$0.272.08%6/2/20256/2/20256/9/20255/2/2025RYANRyan Specialtyquarterly$0.120.7%5/13/20255/13/20255/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTEnact0.151.131.13EQHEquitable2.390.100.10ERIEErie IndemnityN/A1.551.55RYANRyan Specialty3.451.051.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTEnact18.03%EQHEquitable92.70%ERIEErie Indemnity33.67%RYANRyan Specialty84.82%Insider OwnershipCompanyInsider OwnershipACTEnact0.44%EQHEquitable1.10%ERIEErie Indemnity45.79%RYANRyan Specialty52.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTEnact500150.07 million149.41 millionNot OptionableEQHEquitable8,000303.89 million300.55 millionOptionableERIEErie Indemnity6,80146.19 million25.04 millionOptionableRYANRyan Specialty5,250262.43 million125.42 millionOptionableEQH, RYAN, ACT, and ERIE HeadlinesRecent News About These CompaniesArtemis Investment Management LLP Buys Shares of 771,938 Ryan Specialty Holdings Inc. (NYSE:RYAN)1 hour ago | marketbeat.comBessemer Group Inc. Sells 406,135 Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN)June 25 at 7:13 AM | marketbeat.comRyan Specialty Holdings Inc. (NYSE:RYAN) Stock Position Raised by Cooper Investors PTY Ltd.June 24 at 5:46 AM | marketbeat.comNew insurance solution from Ryan Transactional Risk targets environmental remediation costsJune 24 at 3:59 AM | reinsurancene.wsRBrokerages Set Ryan Specialty Holdings Inc. (NYSE:RYAN) Price Target at $75.58June 20, 2025 | americanbankingnews.comChicago’s Ryan Specialty buys 105-year-old Portage firm, opens Livonia officeJune 18, 2025 | crainsgrandrapids.comCRyan Specialty Holdings Inc. (NYSE:RYAN) EVP Sells $946,581.68 in StockJune 18, 2025 | insidertrades.comMark Stephen Katz Sells 14,377 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) StockJune 17, 2025 | marketbeat.comRyan Specialty Holdings, Inc. (NYSE:RYAN) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 17, 2025 | marketbeat.comJPMorgan rainmaker Matthew Demko jumps ship from Jamie Dimon-led bankJune 14, 2025 | msn.comRyan Specialty acquires J.M. WilsonJune 13, 2025 | reinsurancene.wsRBar Harbor Wealth Management Buys 8,226 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)June 13, 2025 | marketbeat.comRyan Specialty Renewables launches to expand global energy insurance capabilitiesJune 12, 2025 | reinsurancene.wsRToth Financial Advisory Corp Takes Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)June 10, 2025 | marketbeat.comInsurance stocks slide as broker data indicates property decelerationJune 9, 2025 | msn.comRyan Specialty (NYSE:RYAN) Shares Down 4.1% - What's Next?June 9, 2025 | marketbeat.comRyan Specialty launches renewables unit to consolidate energy operationsJune 9, 2025 | insurancebusinessmag.comIRyan Specialty to buy Michigan-based insurer JM WilsonJune 9, 2025 | finance.yahoo.comProcyon Advisors LLC Takes Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)June 9, 2025 | marketbeat.comGAMMA Investing LLC Purchases 153,476 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)June 8, 2025 | marketbeat.comRyan Specialty to acquire JM Wilson CorporationJune 7, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesThese 3 Dividend Stocks Combine Strong Yields With UpsideBy Chris Markoch | June 20, 2025View These 3 Dividend Stocks Combine Strong Yields With UpsideAnalyst Downgrades Joby, But Overlooks Major Regulatory WinsBy Jeffrey Neal Johnson | June 17, 2025View Analyst Downgrades Joby, But Overlooks Major Regulatory WinsBigBear.ai: Risky AI Stock or Defense Tech Opportunity?By Jeffrey Neal Johnson | May 28, 2025View BigBear.ai: Risky AI Stock or Defense Tech Opportunity?These 3 Stocks Are Buying Back Billions in SharesBy Leo Miller | June 3, 2025View These 3 Stocks Are Buying Back Billions in SharesWhy Hims & Hers Stock Could Be a Multi-Bagger in the MakingBy Gabriel Osorio-Mazilli | June 24, 2025View Why Hims & Hers Stock Could Be a Multi-Bagger in the MakingEQH, RYAN, ACT, and ERIE Company DescriptionsEnact NASDAQ:ACT$36.85 +0.10 (+0.27%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$36.92 +0.07 (+0.20%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.Equitable NYSE:EQH$56.08 +1.67 (+3.06%) Closing price 06/26/2025 03:59 PM EasternExtended Trading$56.71 +0.63 (+1.13%) As of 08:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Equitable Holdings, Inc., together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through six segments: Individual Retirement, Group Retirement, Investment Management and Research, Protection Solutions, Wealth Management, and Legacy. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related services to various clients through institutional. The Protection Solutions segment provides life insurance products, such as VUL insurance and IUL insurance, term life, and employee benefits business, such as dental, vision, life, as well as short- and long-term disability insurance products to small and medium-sized businesses. The Wealth Management segment offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products. The Legacy segment consists of the capital intensive fixed-rate GMxB business that includes ROP death benefits. The company was formerly known as AXA Equitable Holdings, Inc. and changed its name to Equitable Holdings, Inc. in January 2020. Equitable Holdings, Inc. was founded in 1859 and is based in New York, New York.Erie Indemnity NASDAQ:ERIE$340.73 -0.57 (-0.17%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$344.25 +3.52 (+1.03%) As of 06/26/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. It provides issuance and renewal services; sales related services, including agent compensation, and sales and advertising support services; underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. The company was incorporated in 1925 and is based in Erie, Pennsylvania.Ryan Specialty NYSE:RYAN$67.30 +0.19 (+0.29%) Closing price 06/26/2025 03:59 PM EasternExtended Trading$67.23 -0.07 (-0.11%) As of 07:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
